UBS initiated coverage on Eureka Forbes with a ‘Buy’ call, identifying it as a ‘steady earnings compounder’ with under-appreciated scale advantages in water purifiers and services. The brokerage set a target price of Rs 640, citing market growth driven by health awareness and expanding consumer base.
7 investing lessons from Jim Leitner for building the right market mindset
Leitner believes investors should remain open to new ideas and recognise that markets can challenge even experienced participants.
October 3, 2026